Patents Examined by David Thomas
-
Patent number: 9580746Abstract: A method comprising: synthesizing a set of overlapping oligonucleotides that comprises probe sequences that hybridize to unique sequences in a chromosome, assembling the overlapping oligonucleotides in a way that produces one or more double stranded polynucleotides that each comprises multiple probe sequences, labeling the one or more double stranded polynucleotides to produce one or more labeled probes, and hybridizing the labeled probes to an intact chromosome, in situ, is provided.Type: GrantFiled: January 2, 2014Date of Patent: February 28, 2017Assignee: Agilent Technologies, Inc.Inventors: Emily Marine Leproust, Siyuan Chen, Michael Ruvolo
-
Patent number: 9579650Abstract: Nucleic acid from cells and viruses sampled from a variety of environments may purified and expressed utilizing microfluidic techniques. In accordance with one embodiment of the present invention, individual or small groups of cells or viruses may be isolated in microfluidic chambers by dilution, sorting, and/or segmentation. The isolated cells or viruses may be lysed directly in the microfluidic chamber, and the resulting nucleic acid purified by exposure to affinity beads. Subsequent elution of the purified nucleic acid may be followed by ligation and cell transformation, all within the same microfluidic chip. In one specific application, cell isolation, lysis, and nucleic acid purification may be performed utilizing a highly parallelized microfluidic architecture to construct gDNA and cDNA libraries.Type: GrantFiled: September 23, 2014Date of Patent: February 28, 2017Assignee: California Institute of TechnologyInventors: Jong Wook Hong, Vincent Studer, W. French Anderson, Stephen R. Quake, Jared Leadbetter
-
Patent number: 9574235Abstract: A method for sequencing includes steps of (a) providing first and second nucleic acid templates, wherein the two templates have different sequences; (b) extending a first primer bound to the first template using a first polymerase species and a first set of nucleotide analogs; (c) extending a second primer bound to the second template using a second polymerase species and a second set of nucleotide analogs, wherein the first polymerase species is different from the second polymerase species and wherein the first set of nucleotide analog is different from the second set of nucleotide analog, (d) detecting the first and second primer extension products; and (e) repeating steps (b) through (d), thereby determining the different sequences of the first and second templates.Type: GrantFiled: October 29, 2015Date of Patent: February 21, 2017Assignee: ILLUMINA, INC.Inventors: Martin Maria Fabani, Maria Candelaria Rogert Bacigalupo, John A. Moon
-
Patent number: 9574188Abstract: The disclosed methods in the application relates to making an adapter-tagged restriction library. The library or libraries created with the disclosed methods avoid the self-ligation of the restriction fragments. The application further disclosed methods of using the library or libraries to measure the methylation level of a genome, or comparing methylation levels among two or more genomes. The measurement of the global methylation levels can be achieved with quantitative PCR method by measuring the number of restriction fragments in the libraries. It also can be used for next generation Sequencing (NGS), Copy Number Variation (CNV), restriction site mutation, endogenous gene jumping, and exogenous DNA insertion, somatic hypermutation, gene knockout/knock in etc.Type: GrantFiled: March 31, 2014Date of Patent: February 21, 2017Inventor: Dacheng Ding
-
Patent number: 9567631Abstract: The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing. Such polynucleotide processing may be useful for a variety of applications, including polynucleotide sequencing.Type: GrantFiled: December 12, 2013Date of Patent: February 14, 2017Assignee: 10X GENOMICS, INC.Inventors: Benjamin Hindson, Serge Saxonov, Kevin Ness, Paul Hardenbol
-
Patent number: 9567649Abstract: Methods for the identification of microorganisms or infectious disorders are disclosed, comprising obtaining a suitable sample from sources such as persons, animals, plants, food, water or soil. The methods also comprise providing tailored nucleic acid substrate(s) designed to react with a type 1 topoisomerase from one or more microorganism(s) or infectious agent(s), and incubating said substrate with said sample, or extracts or preparations from the sample, so that the substrate is processed by said topoisomerase if said microorganism(s) or infectious agent(s) is present in the sample. Microfluidic-implemented methods of detecting an enzyme, in particular a DNA-modifying enzyme, are also provided, as well as methods for detecting a cell, or a microorganism expressing said enzyme. The enzyme is detected by providing a nucleic acid substrate, which is specifically targeted by that enzyme.Type: GrantFiled: October 26, 2013Date of Patent: February 14, 2017Inventors: Jørn Erland Koch, Magnus Stougaard, Birgitta Ruth Knudsen, Sissel Juul, Kam Leong, Yi-Ping Ho, Felicie F. Andersen
-
Patent number: 9567635Abstract: The present teachings provide methods, compositions, and kits for performing primer extension reactions. In some embodiments, a reverse transcription reaction is performed on a target polynucleotide with a hot start primer comprising a blunt-ended self-complementary stem, and a loop, and extension products form at high temperatures but reduce extension product formation at low temperatures.Type: GrantFiled: March 12, 2015Date of Patent: February 14, 2017Assignee: Life Technologies CorporationInventors: Kai Lao, Neil Straus, Kenneth Livak
-
Patent number: 9566583Abstract: A method for performing polymerase chain reactions (PCR) for improving thermal non-uniformity is provided. The method includes measuring a first temperature, by a first sensor, of a first sample block sector of a sample block and measuring a second temperature, by a second sensor, of a second sample block sector of the sample block that is adjacent to the first sample block sector. The method further includes calculating, by a thermoelectric controller, a difference in temperature between the first temperature and the second temperature and adjusting, by the thermoelectric controller, the first temperature of the first sample block sector based on the difference in temperature by using one or more thermoelectric coolers. The one or more thermoelectric coolers is configured to heat or cool the first sample block sector by adjusting power output from the thermoelectric controller.Type: GrantFiled: April 8, 2011Date of Patent: February 14, 2017Assignee: Life Technologies CorporationInventors: Thomas Conner, Chee Kiong Lim, Michael Pallas, Chee Wee Ching
-
Patent number: 9534217Abstract: The present invention relates to a method of creating DNA libraries that include an artificial promoter library and/or a modified ribosome binding site library and transforming bacterial host cells with the library to obtain a population of bacterial clones having a range of expression levels for a chromosomal gene of interest.Type: GrantFiled: June 7, 2011Date of Patent: January 3, 2017Assignee: DANISCO US IN.Inventors: Philippe Soucaille, Marguerite A. Cervin, Fernando Valle
-
Patent number: 9534255Abstract: In some embodiments, the present inventions relates generally to compositions, methods and kits for use in discriminating sequence variation between different alleles. More specifically, in some embodiments, the present invention provides for compositions, methods and kits for quantitating rare (e.g., mutant) allelic variants, such as SNPs, or nucleotide (NT) insertions or deletions, in samples comprising abundant (e.g., wild type) allelic variants with high specificity and selectivity. In particular, in some embodiments, the invention relates to a highly selective method for mutation detection referred to as competitive allele-specific TaqMan PCR (“cast-PCR”).Type: GrantFiled: December 17, 2009Date of Patent: January 3, 2017Assignee: LIFE TECHNOLOGIES CORPORATIONInventors: Caifu Chen, Ruoying Tan
-
Patent number: 9529976Abstract: Systems, methods, and devices for detecting infections in a clinical sample are provided. Small-volume clinical samples obtained at a point-of-service (POS) location and may be tested at the POS location for multiple markers for multiple diseases, including upper and lower respiratory diseases. Samples may be tested for cytokines, or for inflammation indicators. Dilution of samples, or levels of detection, may be determined by the condition or past history of a subject. Test results may be obtained within a short amount of time after sample placement in a testing device, or within a short amount of time after being obtained from the subject. A prescription for treatment of a detected disorder may be provided, and may be filled, at the POS location. A bill may be automatically generated for the testing, or for the prescription, may be automatically sent to an insurance provider, and payment may be automatically obtained.Type: GrantFiled: September 5, 2014Date of Patent: December 27, 2016Assignee: Theranos, Inc.Inventors: Clarissa Lui, Elizabeth A. Holmes
-
Patent number: 9527049Abstract: Provided herein, are droplet mixture compositions and systems and methods for forming mixtures of droplets. The system may comprise two or more droplet generation units. Each unit may include at least one first input well, a second input well, and an output well connected to the first and second input wells by channels that form a droplet generator. The combined droplet populations can be mixed, heated, and collected for multiple uses, such as for use as calibration standards for instrument testing and analysis.Type: GrantFiled: June 19, 2013Date of Patent: December 27, 2016Assignee: Bio-Rad Laboratories, Inc.Inventors: Amy L. Hiddessen, Erin R. Chia
-
Patent number: 9528147Abstract: The present disclosure relates to the amplification of target nucleic acid sequences. This can be accomplished via the use of various primers. The use of these primers, as described herein, results in nucleic acid structures that can reduce the amplification of nonspecific hybridization events (such as primer dimerization) while allowing the amplification of the target nucleic acid sequences.Type: GrantFiled: May 27, 2015Date of Patent: December 27, 2016Assignee: Life Technologies CorporationInventors: Kai Lao, Neil Straus
-
Patent number: 9528148Abstract: Methods for multiplex amplification of a plurality of targets of distinct sequence from a complex mixture are disclosed. In one aspect targets are circularized using a single circularization probe that is complementary to two regions in the target that flank a region to be amplified. The targets may hybridize to the circularization probe so that 5? or 3? flaps are generated and methods for removing flaps and circularizing the resulting product are disclosed. In another aspect targets are hybridized to dU probes so that 5? and 3? flaps are generated. The flaps are cleaved using 5? or 3? flap endonucleases or 3? to 5? exonucleases. The target sequences are then ligated to common primers, the dU probes digested and the ligated targets amplified.Type: GrantFiled: March 23, 2015Date of Patent: December 27, 2016Assignee: Affymetrix, Inc.Inventors: Jianbiao Zheng, Li Weng, Malek Faham
-
Patent number: 9523116Abstract: Digital assay system, including methods and apparatus, for calculating a level of one or more targets. In an exemplary method, data for amplification of a plurality of targets including a first target may be collected from partitions. A level of the first target may be calculated from only a subset of the data that excludes partitions according to target content.Type: GrantFiled: February 3, 2014Date of Patent: December 20, 2016Assignee: Bio-Rad Laboratories, Inc.Inventors: Svilen S. Tzonev, Claudia Litterst
-
Patent number: 9523122Abstract: Methods for multiplex amplification of a plurality of targets of distinct sequence from a complex mixture are disclosed. In one aspect targets are circularized using a single circularization probe that is complementary to two regions in the target that flank a region to be amplified. The targets may hybridize to the circularization probe so that 5? or 3? flaps are generated and methods for removing flaps and circularizing the resulting product are disclosed. In another aspect targets are hybridized to dU probes so that 5? and 3? flaps are generated. The flaps are cleaved using 5? or 3? flap endonucleases or 3? to 5? exonucleases. The target sequences are then ligated to common primers, the dU probes digested and the ligated targets amplified.Type: GrantFiled: February 16, 2015Date of Patent: December 20, 2016Assignee: Affymetrix, Inc.Inventors: Jianbiao Zheng, Li Weng, Malek Faham
-
Patent number: 9517472Abstract: The present invention provides a small and low running-cost device capable of minimizing the generation of contamination sources as much as possible while performing a series of all the desired manipulations. A device for manipulating a target component in a manipulation tube, comprising: a manipulation tube comprising a tube having an optionally-closeable open end for supplying a sample containing a target component at one end and a closed end at the other end, and a manipulation medium accommodated in the tube and having a gel layer and an aqueous liquid layer multilayered in a longitudinal direction of the tube; magnetic particles that should transport the target component; and magnetic field applying means capable of applying a magnetic field to the manipulation tube to move the magnetic particles in the longitudinal direction of the tube.Type: GrantFiled: July 13, 2011Date of Patent: December 13, 2016Assignee: SHIMADZU CORPORATIONInventor: Tetsuo Ohashi
-
Patent number: 9518258Abstract: The current invention relates to a method for targeted alteration of acceptor DNA, for example duplex acceptor DNA. The method comprises use of at least two oligonucleotides, each oligonucleotide having at least one mismatch relative to the targeted (duplex) acceptor DNA. The mismatch of the first oligonucleotide is directed to a nucleotide at a position in the first strand of the duplex and the mismatch of the second oligonucleotide is directed to the nucleotide in the second strand that occupies the complementary position in the duplex acceptor DNA (e.g. forms a base-pair with the nucleotide in the first strand). These mismatches are located at specific positions within said oligonucleotides. Also provided is a kit that comprises instructions for performing the method according to the inventions, and in a preferred embodiment, comprises oligonucleotides suitable for use in the method.Type: GrantFiled: November 25, 2011Date of Patent: December 13, 2016Assignee: KEYGENE N.V.Inventors: Michiel Theodoor Jan De Both, Tomoyuki Furukawa
-
Patent number: 9518982Abstract: Methods for detecting multiple targets in a biological sample are provided. The methods includes contacting the sample with a first probe; physically binding the first probe to a first target; observing a first signal from the first probe; applying a chemical agent to modify the first signal; contacting the sample with a second probe; physically binding the second probe to a second target; and observing a second signal from the second probe. The methods disclosed herein also provide for multiple iterations of binding, observing, signal modification for deriving information about multiple targets in a single sample. An associated kit and device are also provided.Type: GrantFiled: November 3, 2009Date of Patent: December 13, 2016Assignee: GENERAL ELECTRIC COMPANYInventors: Anup Sood, Michael Christopher Montalto, Michael Gerdes, Maximilian Lewis Seel, Robert John Filkins
-
Patent number: 9512494Abstract: The present invention relates to a method for amplifying and detecting a target nucleic acid of HCV in a sample, wherein an amplification of the nucleic acids in said sample is carried out. This amplification involves a polymerase, primers for generating an amplicon and at least two detectable probes specific for different sequence portions of said amplicon. Detection of the obtained amplicon is brought about by detecting hybridization of the probes mentioned above to said different sequence portions of the amplicon. The invention further provides reaction mixtures and kits for amplifying and detecting a target nucleic acid of HCV involving the use of at least two detectable probes specific for different sequence portions of an amplicon.Type: GrantFiled: October 16, 2013Date of Patent: December 6, 2016Assignee: Roche Molecular Systems, Inc.Inventors: Frank Bergmann, Dorothea Sizmann, Heike Zitzer